Global Chlorhexidine Gluconate (CHG) Wipes Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Chlorhexidine Gluconate (CHG) Bath Wipes and Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes.

By Application;

Surgical Site Infections, Central Line-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections, and Others.

By Distribution Channel;

Pharmacies, Supermarkets, Specialty Stores, and Direct Sales.

By End User;

Hospitals, Clinics, Ambulatory Surgical Centers, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn114105841 Published Date: February, 2025 Updated Date: March, 2025

Introduction

Global Chlorhexidine Gluconate (CHG) Wipes Market (USD Million), 2021 - 2031

In the year 2024, the Global Chlorhexidine Gluconate (CHG) Wipes Market was valued at USD 14,562.64 million. The size of this market is expected to increase to USD 19,685.37 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.

The Global Chlorhexidine Gluconate (CHG) Wipes Market is poised for substantial growth, driven by the increasing emphasis on infection prevention and control in healthcare settings worldwide. CHG wipes, infused with the antimicrobial agent chlorhexidine gluconate, offer a convenient and effective solution for disinfecting skin and surfaces, thereby reducing the risk of healthcare-associated infections (HAIs) and improving patient safety outcomes. As healthcare facilities prioritize stringent hygiene protocols and antimicrobial stewardship initiatives, the demand for CHG wipes is expected to surge, particularly in surgical and medical settings where infection prevention is paramount.
These wipes are impregnated with chlorhexidine gluconate, a broad-spectrum antimicrobial agent known for its efficacy against a wide range of bacteria, fungi, and viruses. CHG wipes are widely used for pre-operative skin preparation, central line insertion site care, and daily bathing of patients to reduce the risk of HAIs.

The CHG wipes market is characterized by ongoing product innovations, technological advancements, and regulatory developments aimed at enhancing product efficacy, safety, and usability. Manufacturers are investing in research and development initiatives to improve CHG wipe formulations, optimize delivery mechanisms, and address potential side effects, ensuring optimal patient outcomes and satisfaction.

Key market players in the global CHG wipes market include Becton, Dickinson And Company, 3M, Sage Products LLC (Stryker), Clinicept Healthcare Ltd, Coloplast Corp, Convatec, Cardinal Health, GAMA Healthcare Ltd, Medline Industries Inc., and Mlnlycke Health Care AB. These companies offer a diverse portfolio of CHG wipes catering to the specific needs of healthcare facilities and patients, thereby contributing to market growth and innovation. The CHG wipes market is driven by factors such as the increasing prevalence of HAIs, growing awareness of infection control measures, and rising healthcare expenditure. As healthcare systems worldwide prioritize patient safety and infection prevention, CHG wipes are expected to play a vital role in reducing HAIs and improving clinical outcomes. With continued investments in research, innovation, and regulatory compliance, the CHG wipes market is poised to witness significant growth and adoption, offering healthcare stakeholders an indispensable tool in the fight against infectious diseases.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Chlorhexidine Gluconate (CHG) Wipes Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Awareness of Antimicrobial Resistance

        2. Surge in Surgical Procedures

        3. Increasing Emphasis on Infection Prevention

      2. Restraints
        1. Potential Side Effects

        2. Cost Considerations

        3. Limited Awareness and Education

      3. Opportunities
        1. Expansion of Healthcare Infrastructure

        2. Expansion into Non-Healthcare Sectors

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Chlorhexidine Gluconate (CHG) Wipes Market, By Type, 2021 - 2031 (USD Million)
      1. Chlorhexidine Gluconate (CHG) Bath Wipes
      2. Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes
    2. Global Chlorhexidine Gluconate (CHG) Wipes Market, By Application, 2021 - 2031 (USD Million)
      1. Surgical Site Infections
      2. Central Line-Associated Bloodstream Infections
      3. Catheter-Associated Urinary Tract Infections
      4. Others
    3. Global Chlorhexidine Gluconate (CHG) Wipes Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Pharmacies
      2. Supermarkets
      3. Specialty Stores
      4. Direct Sales
    4. Global Chlorhexidine Gluconate (CHG) Wipes Market, By End User, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Clinics

      3. Ambulatory Surgical Centers

      4. Others

    5. Global Chlorhexidine Gluconate (CHG) Wipes Market, By Geography, 2021 - 2031 (USD Million)
      1. North America

        1. United States

        2. Canada

      2. Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Nordic

        7. Benelux

        8. Rest of Europe

      3. Asia Pacific

        1. Japan

        2. China

        3. India

        4. Australia & New Zealand

        5. South Korea

        6. ASEAN (Association of South East Asian Countries)

        7. Rest of Asia Pacific

      4. Middle East & Africa

        1. GCC

        2. Israel

        3. South Africa

        4. Rest of Middle East & Africa

      5. Latin America

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

  6. Competitive Landscape
    1. Company Profiles
      1. Becton Dickinson and Company

      2. 3M

      3. Cardinal Health

      4. GAMA Healthcare Ltd

      5. Carenow Medical Pvt. Ltd.

      6. PDI Limited

      7. Lernapharm Inc.

      8. Pal International

  7. Analyst Views
  8. Future Outlook of the Market